PATENT CLAIM ANALYSIS

Application Number: 15771005
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "182000"]

Abstract:
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit Hedgehog signaling. Also described herein are methods for using such Hedgehog signaling inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of Hedgehog signaling.

Claim (Index 35):
The method of  claim 34 , wherein the cancer is selected from basal cell carcinoma, melanoma, leukemia, multiple myeloma, stomach cancer, pancreatic cancer, bladder cancer, prostate cancer, ovarian cancer, bone cancer, brain cancer, lung cancer, breast cancer, liver cancer, colon cancer, rhabdomyosarcoma, and skin cancer.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 91.0
- Lexical Diversity: 1.36111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15055402', '13448737', '13662135', '15552442', '15923668']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7775063665866484
- 35 USC 102 Novelty (BERT): 0.5941437086434053
- Combined Prediction Score: 0.7591701007923242
- Mean Citation Score: 339.204426
- Max Citation Score: 580.3826
- Similarity Product: 412.1380184703589

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test